Suffolk University

Provation Selects Anita Santos as its Chief Marketing Officer

Retrieved on: 
Thursday, April 6, 2023
Health, Technology, Practice Management, Health Technology, Managed Care, Software, General Health, Software as a service, Fortune 1000, Executive, Sigma-Aldrich, Marketing, National Association of Corporate Directors, FTV, Provat Lakra, Fortive, Thermo Fisher Scientific, KLAS, CMO, Apex, Hospital, MD, EHR, Engineering, Corporation, Merrimack College, NACD, Growth, National Association, Suffolk University, NYSE, Management

Provation, a leading provider of healthcare productivity and workflow automation software solutions, and a wholly-owned operating company of Fortive Corporation (NYSE: FTV), today announced the appointment of Anita Santos as Chief Marketing Officer (CMO).

Key Points: 
  • Provation, a leading provider of healthcare productivity and workflow automation software solutions, and a wholly-owned operating company of Fortive Corporation (NYSE: FTV), today announced the appointment of Anita Santos as Chief Marketing Officer (CMO).
  • “Anita is a transformational growth leader with extensive financial acumen, and proven success in technically complex industries,” commented Ankush Kaul, President of Provation.
  • “I am excited to join the Provation team and help the company expand market share and increase revenue,” commented Anita Santos, Chief Marketing Officer, Provation.
  • Provation’s comprehensive portfolio spans the entire patient encounter, from pre-procedure through post-procedure, with solutions for physician and nursing documentation ( Provation® MD , Provation® Apex , MD-Reports, Provation® endoPRO® , and Provation® MultiCaregiver ), anesthesia documentation (#1 Best in KLAS Provation® iPro ), patient engagement, surgical care coordination, quality reporting, and billing capture ( Provation® SurgicalValet ™), order set and care plan management ( Provation® Order Set Advisor ™ and Provation® Care Plans ), and EHR embedded clinical documentation (Provation® Clinic Note).

Glyscend Therapeutics Appoints Biotech Industry Veteran Michael Wyzga to its Board of Directors

Retrieved on: 
Thursday, March 30, 2023
Health, Diabetes, Other Health, Clinical Trials, Pharmaceutical, Biotechnology, Gaucher's disease, Genzyme, OncoMed, Chronic lymphocytic leukemia, MBA, Providence College, Strategic planning, Type 2, Patient, Hyperphosphatemia, Fabry disease, Therapy, Suffolk University, Imiglucerase, Sevelamer, Pharmaceutical industry, Management

Glyscend Therapeutics , a clinical-stage biotechnology company pioneering a new generation of orally administered polymer therapies, today announced the appointment of Michael Wyzga to its Board of Directors.

Key Points: 
  • Glyscend Therapeutics , a clinical-stage biotechnology company pioneering a new generation of orally administered polymer therapies, today announced the appointment of Michael Wyzga to its Board of Directors.
  • Mr. Wyzga brings over two decades of deep experience leading and advising life sciences companies to the Glyscend Board.
  • “We are thrilled to welcome Mike, a distinguished biotech industry expert, to the Glyscend team,” said Ashish Nimgaonkar, M.D., President and CEO of Glyscend.
  • I, along with the rest of the Board, look forward to his partnership.”
    Mr. Wyzga added, “I’m pleased to join the Glyscend Board of Directors during this exciting time for the company.

Impact of independent, nonprofit colleges and universities in Massachusetts stands at $71B annually

Retrieved on: 
Thursday, March 30, 2023
Workforce, Maintenance, Music, McCarron, Education, Nursing, University, National Association of Independent Colleges and Universities, Greater Boston, Research, Associate, School, Student, Work, Investment, Capital, ESI, STEM, Weather, Ecosystem, Suffolk University, Creative industries, Health insurance, Tutoring, Tourism, Commonwealth

BELMONT, Mass., March 30, 2023 /PRNewswire/ -- The Association of Independent Colleges and Universities of Massachusetts (AICU Mass), which represents fifty-nine independent, nonprofit colleges and universities across the Commonwealth, today released an economic impact study that demonstrates the statewide annual impact in Massachusetts of its members at $71.1B.

Key Points: 
  • BELMONT, Mass., March 30, 2023 /PRNewswire/ -- The Association of Independent Colleges and Universities of Massachusetts (AICU Mass), which represents fifty-nine independent, nonprofit colleges and universities across the Commonwealth, today released an economic impact study that demonstrates the statewide annual impact in Massachusetts of its members at $71.1B.
  • "This Economic Impact Study puts that into hard numbers that quantify just how crucial.
  • Taken together, they are one of the most important anchors of our robust and vibrant knowledge-based economy."
  • "This report should serve as a critical reminder of the tremendous impact of the private colleges and universities in the state, not just those detailed in the report, but those less quantifiable, added McCarron.

Kelly Aylward Joins Goulston & Storrs' Boston Office as a Director in the Private Client & Trust Group

Retrieved on: 
Monday, March 27, 2023
University, Aylward, Property Trust Group, LLM, American College of Trust and Estate Counsel, Boston Bar Association, Estate, Lawyer, Boston University School of Law, Organization, Greater Boston, Inn of Court, The Boston Foundation, American College, Suffolk University, Suffolk University Law School, American Inn, Real estate, Property management

BOSTON, March 27, 2023 /PRNewswire/ -- Goulston & Storrs , an Am Law 200 firm, is pleased to announce that Kelly Aylward has joined its Boston office as a director in the firm's Private Client & Trust Group.

Key Points: 
  • BOSTON, March 27, 2023 /PRNewswire/ -- Goulston & Storrs , an Am Law 200 firm, is pleased to announce that Kelly Aylward has joined its Boston office as a director in the firm's Private Client & Trust Group.
  • Prior to joining Goulston & Storrs, she was a principal at a boutique trusts and estate law firm in Boston.
  • "We are very excited to have Kelly join our world-class Private Client & Trust Group.
  • "Kelly's broad expertise in complicated trust, estate, and tax planning matters will be invaluable to our clients and our firm."

Former Xpansiv Executive Chairman, Will Stewart, Joins Imperative Global as Chairman of the Board

Retrieved on: 
Tuesday, March 7, 2023
Environmental, Social and Governance (ESG), Other Professional Services, Green Technology, Climate Change, Sustainability, Technology, Finance, Professional Services, Other Natural Resources, Environment, Forest Products, Environmental Health, Agriculture, Natural Resources, Other Technology, Silicon, MBA, Global Media & Entertainment, NEC, Suffolk University, Carbon, APV, Saint Anselm College, Executive, ESG, Investment, Lightspeed Venture Partners, Management, Renewable energy, Economics

Imperative Global Group, Inc. (“Imperative”), a market-leading carbon offset project developer and operator, announced today that Will Stewart, current Board Member, Investor, and former Executive Chairman of Xpansiv, has joined the company as Chairman of the Board of Directors.

Key Points: 
  • Imperative Global Group, Inc. (“Imperative”), a market-leading carbon offset project developer and operator, announced today that Will Stewart, current Board Member, Investor, and former Executive Chairman of Xpansiv, has joined the company as Chairman of the Board of Directors.
  • Stewart has been a board member of dozens of global private and public companies over the span of his 30-year professional technology and finance career, including numerous high-profile ESG companies.
  • He brings an abundance of global tech, ESG, corporate growth, planning, and financial experience to Imperative.
  • “We are delighted to formally welcome Will to the Board,” said Imperative CEO, Scobie Mackay.

Maxx Orthopedics announces Farzin Khaghani as Chief Commercial Officer

Retrieved on: 
Tuesday, March 7, 2023
Harmonia conformis, Engineering, Queen (chess), Cornell University, Sawyer Business School, Marketing, Boston University, MS, Suffolk University, Biomedical sciences, Orthopedic surgery, Johnson & Johnson, Biology, University, Mathematics, BS, Postgraduate education, Management

NORRISTOWN, Pa., March 7, 2023 /PRNewswire-PRWeb/ -- Maxx Orthopedics, Inc., a rapidly expanding global orthopedics device company, announced today that Farzin Khaghani has joined the organization in the newly created role of Chief Commercial Officer. This will better position Maxx Orthopedics to improve and drive its strategic initiatives within the US market. Mr. Khaghani will be responsible for mobilizing the full commercial power of the organization, from sales and marketing to profit and revenue generation.

Key Points: 
  • Maxx Orthopedics, Inc., a rapidly expanding global orthopedics device company, announced today that Farzin Khaghani has joined the organization in the newly created role of Chief Commercial Officer.
  • NORRISTOWN, Pa., March 7, 2023 /PRNewswire-PRWeb/ -- Maxx Orthopedics, Inc., a rapidly expanding global orthopedics device company, announced today that Farzin Khaghani has joined the organization in the newly created role of Chief Commercial Officer.
  • This will better position Maxx Orthopedics to improve and drive its strategic initiatives within the US market.
  • Mr. Khaghani will be responsible for mobilizing the full commercial power of the organization, from sales and marketing to profit and revenue generation.

Harsco Corporation Announces Election of Timothy Laurion to Its Board of Directors and Resignation of Mario Longhi as Director

Retrieved on: 
Tuesday, February 28, 2023
Laurium, U.S. Steel, Bowdoin College, NYSE, Bank of America, Harsco, Acquisition, HSC, Business administration, Bank, Ecosystem, Suffolk University, Chartered Financial Analyst, Growth, Master of Business Administration, Investment banking, Longhi, Management

PHILADELPHIA, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Harsco Corporation (NYSE: HSC) announced today that it has elected Timothy M. Laurion, 64, to its Board of Directors.

Key Points: 
  • PHILADELPHIA, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Harsco Corporation (NYSE: HSC) announced today that it has elected Timothy M. Laurion, 64, to its Board of Directors.
  • Concurrently, the Company also announced today that Mario Longhi resigned from the Board of Directors, effective February 23, due to other time commitments.
  • Longhi, 67, the retired President and Chief Executive Officer of United States Steel Corporation, was elected to Harsco’s Board of Directors in November 2017.
  • His resignation from the Board is not due to any disagreement with the Company on any matter relating to its operations, policies or practices.

JVS Boston Names Kira Khazatsky as New CEO

Retrieved on: 
Thursday, February 16, 2023
Human Resources, Religion, Professional Services, Philanthropy, Continuing, University, Consumer, Foundation, Other Philanthropy, Education, Newton, Superintendent, Biotechnology, Massachusetts General Hospital, Clark University, Suffolk University, Psychology, Quincy College, Social justice, JVS, Workforce, Mass General Brigham, Family, Arlington Street Church, Partnership, Health, Multimedia, Employment, Mass, Organizational learning, Love, School, Management, Nursing, Adult

Jewish Vocational Service Boston ( JVS Boston ), one of New England’s largest providers of adult education and workforce development services, today announced the appointment of Kira Khazatsky as the agency’s new President and Chief Executive Officer.

Key Points: 
  • Jewish Vocational Service Boston ( JVS Boston ), one of New England’s largest providers of adult education and workforce development services, today announced the appointment of Kira Khazatsky as the agency’s new President and Chief Executive Officer.
  • View the full release here: https://www.businesswire.com/news/home/20230216005726/en/
    KIRA KHAZATSKY has been named the new president and CEO of JVS Boston, one of New England’s largest providers of adult education and workforce development services.
  • JVS Boston board chair Abby Flam said: “All of us who are leaders and supporters of JVS Boston know what an effective, proven, dynamic leader Kira is and how well-prepared she is to take JVS Boston to the next level as our new CEO, starting from day one.
  • I am thrilled that JVS has named Kira their President and CEO and look forward to many more wonderful years of collaboration.”
    Jerry Rubin , former JVS Boston President and CEO said: “Kira is a fantastic choice to lead JVS Boston.

Sensorium Therapeutics Appoints Jeffrey M. Brown as Chief Scientific Officer

Retrieved on: 
Wednesday, January 18, 2023
Bristol Myers Squibb, Suffolk University, University, Therapy, Mental health, Depression, Biotechnology, Anxiety, Machine learning, Fungus, BDP, Amgen, Neuroscience, Drug discovery, Patient, Alexion Pharmaceuticals, Research, Human, MBA, Nature, Doctor of Philosophy, Management, Pharmaceutical industry, Sensorium, Pfizer

BOSTON, Jan. 18, 2023 /PRNewswire/ -- Sensorium Therapeutics (Sensorium), a biotechnology company leveraging medicinal chemistry, neuroscience, and machine learning to develop nature-inspired psychoactive medicines for mental health, today announced the appointment of Jeffrey M. Brown, Ph.D., MBA as Chief Scientific Officer.

Key Points: 
  • BOSTON, Jan. 18, 2023 /PRNewswire/ -- Sensorium Therapeutics (Sensorium), a biotechnology company leveraging medicinal chemistry, neuroscience, and machine learning to develop nature-inspired psychoactive medicines for mental health, today announced the appointment of Jeffrey M. Brown, Ph.D., MBA as Chief Scientific Officer.
  • "We are thrilled to strengthen our scientific leadership at this critical phase of development for the company," said Dick Simon, Chief Executive Officer of Sensorium.
  • Dr. Brown joins Sensorium from Deep Genomics, where he served as Vice President and Head of Preclinical Research, advancing the company's discovery pipeline for antisense oligonucleotide therapeutics.
  • Prior to Deep Genomics, he held leadership positions at Voyager Therapeutics, Wave Life Sciences, and Alexion Pharmaceuticals.

Bullhorn Promotes Kelley Morse to Chief People Officer

Retrieved on: 
Wednesday, January 11, 2023
Technology, Human Resources, Labor, Consulting, Public Policy, Government, Professional Services, Software, Internet, Data Management, Suffolk University, HR, Nike Flywire, Learning, Human resources, Culture, Senior, BIPOC, Organization, Morse, Gustavus Adolphus College, Acquisition, Cloud computing, Management, Megaphone

Bullhorn, the cloud computing company that helps staffing and recruiting organizations transform their businesses, has promoted Kelley Morse to Chief People Officer.

Key Points: 
  • Bullhorn, the cloud computing company that helps staffing and recruiting organizations transform their businesses, has promoted Kelley Morse to Chief People Officer.
  • Morse has a long history of helping organizations scale while building agile, high-performing teams.
  • Morse also oversaw the implementation of new performance management and compensation tools, as well as a new leadership training program.
  • “I am really excited to continue my work at Bullhorn as Chief People Officer,” said Morse.